Keyphrases
Apoptosis
5%
B-cell Lymphoma 2 (Bcl-2)
5%
Bcl-2 Expression
11%
Breast Cancer
100%
Breast Tumor Tissues
11%
Clinical Markers
5%
Cyclooxygenase-2
22%
Cyclooxygenase-2 Expression
11%
Fragile Histidine Triad
100%
High Proliferation Index
5%
Histological Markers
5%
Immunohistochemistry
5%
Inverse Correlation
11%
Ki-67
5%
Large Trials
5%
Long Follow-up
5%
Lymph Node Positive
11%
Metastatic Axillary Lymph Node
22%
Metastatic Lymph Node
5%
Oncogenesis
5%
P53 Expression
11%
Poor Prognostic
5%
Poor Prognostic Marker
100%
Predictive Value
5%
Primary Breast Tumor
33%
Primary Tumor
16%
Prognostic Features
5%
Prognostic Value
5%
Same Patient
5%
Tissue Expression
5%
Tumor Grade
5%
Tumor Size
5%
Tumor Specimens
5%
Tumor Suppressor Gene
5%
Immunology and Microbiology
Axillary Lymph Node
100%
Bcl-2
75%
Lymph Node
75%
P53
100%
Tumor Suppressor Gene
25%
Tumor Volume
25%
Medicine and Dentistry
Axillary Lymph Node
22%
Breast Cancer
100%
Breast Tumor
33%
Carcinogenesis
5%
Cyclooxygenase 2
33%
Histidine
100%
Immunohistochemistry
5%
Lymph Node
11%
Lymph Node Metastasis
5%
Neoplasm
5%
Primary Tumor
16%
Programmed Cell Death
5%
Protein P53
22%
Tumor Suppressor Gene
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Breast Tumor
33%
Carcinogenesis
5%
Cyclooxygenase 2
33%
Histidine
100%
Lymph Node Metastasis
5%
Neoplasm
5%
Primary Tumor
16%
Protein P53
22%
Tumor Suppressor Protein
5%